Pluri Inc. Restricted Cash
Pluri Inc. (PLUR) had Restricted Cash of $254.00 thousand as of 2024-06-30, per its 10-K filed 2024-09-18.
Discontinued › Balance Sheet › Assets › Restricted Cash and Investments
us-gaap:RestrictedCash · last filed 2024-09-18
- 2024-06-30: Restricted Cash $254.00K.
- 2024-03-31: Restricted Cash $273.00K.
- 2023-12-31: Restricted Cash $373.00K.
- 2023-09-30: Restricted Cash $295.00K.
| Period end | Restricted Cash | Restricted Cash as first filed |
|---|---|---|
| 2024-06-30 | $254.00K 10-K · filed 2024-09-18 | |
| 2024-03-31 | $273.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $373.00K 10-Q · filed 2024-02-12 | |
| 2023-09-30 | $295.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $269.00K 10-K · filed 2024-09-18 | |
| 2023-03-31 | $273.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $753.00K 10-Q · filed 2023-02-13 | |
| 2022-09-30 | $653.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.01M 10-K · filed 2023-09-12 | $634.00K 10-K · filed 2022-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |